Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 13 - Number 13





Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis

, 13(13): 1327 - 1333

Richard C. Baybutt, Betty L. Herndon, Joshua Umbehr, Jonathan Mein, Yuan Xue, Sara Reppert, Christine Van Dillen, Robin Kamal, Anirudha Halder and Agostino Molteni


DOI: 10.2174/138161207780618803



Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine

, 13(13): 1347 - 1361

H. P. Lefebvre, S. A. Brown, V. Chetboul, J. N. King, J.-L. Pouchelon and P. L. Toutain


DOI: 10.2174/138161207780618830





Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32

Advertisement

September Health DaysCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog